MoneyWorks4Me

The Total revenue for the quarter ended December 2021 of  Rs. 330.02 millions remain, more or less, the same.Profit after tax improved marginally to Rs. 62.26  millions for the quarter ended December 2021 from Rs. 59.46 millions of corresponding previous quarter.The company reported a good operating profit of 82.58 millions compared to 80.67 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 330.02 318.19 3.72 956.90 797.35 20.01 1092.94 1188.91 -8.07
Other Income 12.85 10.50 22.38 36.71 30.49 20.40 43.08 42.18 2.13
PBIDT 82.58 80.67 2.37 262.72 178.63 47.07 241.52 239.63 0.79
Interest 1.01 1.17 -13.68 3.13 3.53 -11.33 4.74 5.26 -9.89
PBDT 81.57 79.50 2.60 259.59 175.10 48.25 236.78 234.37 1.03
Depreciation 4.73 5.08 -6.89 13.61 15.08 -9.75 20.35 22.99 -11.48
PBT 76.84 74.42 3.25 245.98 160.02 53.72 216.43 211.38 2.39
TAX 14.58 14.96 -2.54 57.51 33.77 70.30 51.39 62.68 -18.01
Deferred Tax -0.42 1.46 -128.77 -1.77 -3.58 -50.56 -3.91 3.69 -205.96
PAT 62.26 59.46 4.71 188.47 126.25 49.28 165.04 148.70 10.99
Equity 45.89 45.89 0.00 45.89 45.89 0.00 45.89 45.89 0.00
PBIDTM(%) 25.02 25.35 -1.30 27.46 22.40 22.55 22.10 20.16 9.64
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..